StockMacro
Menu

Capricor Therapeutics

CAPR on XNAS, Capricor Therapeutics Inc

Measures activity, not value. Not investment advice.

Shares sold short (30 Oct 2026)

18.8M

-5.5% vs the report before

Short interest, % of shares outstanding

32%

58.1M shares outstanding (9 Nov 2026)

Days to cover

7.4

short interest / daily volume

Short sale volume share (20 Nov 2026)

65%

1-year median 52%

Sharp changes

22

short interest spike

Window
18.8M shares sold short on 30 Oct 2026, 32% of shares outstanding, 7.4 days to cover

FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.

See the numbers
30 Oct 2026: 18.8M shares sold short, 7.4 days to cover
15 Oct 2026: 19.9M shares sold short, 6.6 days to cover
30 Sep 2026: 18.8M shares sold short, 4.5 days to cover
15 Sep 2026: 19.7M shares sold short, 5.9 days to cover
31 Aug 2026: 22.2M shares sold short, 2.0 days to cover
14 Aug 2026: 17.8M shares sold short, 1.6 days to cover
31 Jul 2026: 16.0M shares sold short, 2.1 days to cover
15 Jul 2026: 15.6M shares sold short, 10.8 days to cover
30 Jun 2026: 14.7M shares sold short, 7.4 days to cover
15 Jun 2026: 11.7M shares sold short, 13.7 days to cover
29 May 2026: 11.1M shares sold short, 14.3 days to cover
15 May 2026: 10.9M shares sold short, 8.2 days to cover
30 Apr 2026: 10.5M shares sold short, 12.7 days to cover
15 Apr 2026: 10.0M shares sold short, 9.5 days to cover
31 Mar 2026: 9.9M shares sold short, 6.7 days to cover
13 Mar 2026: 7.3M shares sold short, 4.0 days to cover
27 Feb 2026: 6.9M shares sold short, 5.8 days to cover
13 Feb 2026: 6.6M shares sold short, 7.3 days to cover
30 Jan 2026: 5.9M shares sold short, 4.9 days to cover
15 Jan 2026: 5.1M shares sold short, 3.4 days to cover
31 Dec 2025: 5.1M shares sold short, 4.6 days to cover
15 Dec 2025: 5.0M shares sold short, 1.0 days to cover
28 Nov 2025: 16.4M shares sold short, 7.2 days to cover
14 Nov 2025: 14.2M shares sold short, 7.9 days to cover
31 Oct 2025: 13.3M shares sold short, 10.8 days to cover
15 Oct 2025: 12.2M shares sold short, 11.3 days to cover
30 Sep 2025: 11.7M shares sold short, 7.2 days to cover
15 Sep 2025: 12.1M shares sold short, 11.2 days to cover
29 Aug 2025: 11.5M shares sold short, 8.5 days to cover
15 Aug 2025: 11.4M shares sold short, 7.7 days to cover
31 Jul 2025: 11.1M shares sold short, 4.9 days to cover
15 Jul 2025: 9.8M shares sold short, 2.9 days to cover
30 Jun 2025: 11.2M shares sold short, 2.5 days to cover
13 Jun 2025: 10.2M shares sold short, 4.7 days to cover
30 May 2025: 11.1M shares sold short, 5.1 days to cover
15 May 2025: 13.8M shares sold short, 3.4 days to cover
30 Apr 2025: 10.3M shares sold short, 7.5 days to cover
15 Apr 2025: 10.7M shares sold short, 8.1 days to cover
31 Mar 2025: 9.3M shares sold short, 5.5 days to cover
14 Mar 2025: 9.1M shares sold short, 5.5 days to cover
28 Feb 2025: 8.2M shares sold short, 6.6 days to cover
14 Feb 2025: 8.2M shares sold short, 8.5 days to cover
31 Jan 2025: 7.7M shares sold short, 10.9 days to cover
15 Jan 2025: 7.6M shares sold short, 8.2 days to cover
31 Dec 2024: 8.0M shares sold short, 6.0 days to cover
13 Dec 2024: 5.6M shares sold short, 2.9 days to cover
29 Nov 2024: 4.4M shares sold short, 3.9 days to cover
15 Nov 2024: 3.8M shares sold short, 3.5 days to cover
31 Oct 2024: 5.3M shares sold short, 2.8 days to cover
15 Oct 2024: 6.2M shares sold short, 1.2 days to cover
30 Sep 2024: 5.2M shares sold short, 1.0 days to cover
13 Sep 2024: 7.5M shares sold short, 46.0 days to cover
30 Aug 2024: 7.5M shares sold short, 29.7 days to cover
15 Aug 2024: 7.0M shares sold short, 17.0 days to cover
31 Jul 2024: 6.2M shares sold short, 22.8 days to cover
15 Jul 2024: 5.9M shares sold short, 13.7 days to cover
28 Jun 2024: 4.7M shares sold short, 6.0 days to cover
14 Jun 2024: 4.5M shares sold short, 12.9 days to cover
31 May 2024: 4.6M shares sold short, 10.8 days to cover
15 May 2024: 4.2M shares sold short, 16.5 days to cover

What the numbers say

  • 18.8M shares sold short on 30 Oct 2026, 32% of shares outstanding, 7.4 days to cover; -5.5% on the report before (published by FINRA on 10 Nov 2026).

Every measure from this source

Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.

Days to cover. 7.4 days in the report of 30 Oct 2026, 7.9 a year earlier.
Short interest, % of shares outstanding. 32% in the report of 30 Oct 2026, 31% a year earlier.
Daily short sale volume share on off-exchange venues. 65% of the off-exchange volume on 20 Nov 2026 was a short sale; its median of the last 12 months 52%. This is a daily flow, not short interest.

Sharp changes

22 in all loaded history, strongest first

Capricor Therapeutics had 3.2M shares sold short in the 15 Mar 2024 report, 9.1× the same report last year.

Short interest spike, became public on 27 Mar 2024

Same report last year: 353K; its normal report is 474K.

See the evidence
This period
3.2M (the 15 Mar 2024 report)
Normal report (median of 24 earlier)
474K
Typical spread (median absolute deviation)
213K
How far from its usual level
+8.7
Same report last year
353K
History used
2,268 days
2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.7M2024-02-15: 2.7M2024-02-29: 2.7M2024-03-15: 3.2M
the 15 Mar 2024 report24 earlier reportsnormal: 474K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Capricor Therapeutics had 2.7M shares sold short in the 29 Feb 2024 report, 8.0× the same report last year.

Short interest spike, became public on 12 Mar 2024

Same report last year: 338K; its normal report is 377K.

See the evidence
This period
2.7M (the 29 Feb 2024 report)
Normal report (median of 24 earlier)
377K
Typical spread (median absolute deviation)
120K
How far from its usual level
+13.0
Same report last year
338K
History used
2,253 days
2023-02-28: 338K2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.7M2024-02-15: 2.7M2024-02-29: 2.7M
the 29 Feb 2024 report24 earlier reportsnormal: 377K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Capricor Therapeutics had 2.7M shares sold short in the 12 Jan 2024 report, 7.8× the same report last year.

Short interest spike, became public on 25 Jan 2024

Same report last year: 343K; its normal report is 333K.

See the evidence
This period
2.7M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
333K
Typical spread (median absolute deviation)
68K
How far from its usual level
+23.4
Same report last year
343K
History used
2,205 days
2023-01-13: 343K2023-01-31: 328K2023-02-15: 311K2023-02-28: 338K2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M2024-01-12: 2.7M
the 12 Jan 2024 report24 earlier reportsnormal: 333K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Capricor Therapeutics had 2.7M shares sold short in the 31 Jan 2024 report, 8.2× the same report last year.

Short interest spike, became public on 10 Feb 2024

Same report last year: 328K; its normal report is 333K.

See the evidence
This period
2.7M (the 31 Jan 2024 report)
Normal report (median of 24 earlier)
333K
Typical spread (median absolute deviation)
68K
How far from its usual level
+23.2
Same report last year
328K
History used
2,224 days
2023-01-31: 328K2023-02-15: 311K2023-02-28: 338K2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.7M
the 31 Jan 2024 report24 earlier reportsnormal: 333K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Capricor Therapeutics had 2.7M shares sold short in the 15 Feb 2024 report, 8.6× the same report last year.

Short interest spike, became public on 28 Feb 2024

Same report last year: 311K; its normal report is 346K.

See the evidence
This period
2.7M (the 15 Feb 2024 report)
Normal report (median of 24 earlier)
346K
Typical spread (median absolute deviation)
84K
How far from its usual level
+18.6
Same report last year
311K
History used
2,239 days
2023-02-15: 311K2023-02-28: 338K2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M2024-01-12: 2.7M2024-01-31: 2.7M2024-02-15: 2.7M
the 15 Feb 2024 report24 earlier reportsnormal: 346K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Capricor Therapeutics had 2.4M shares sold short in the 29 Dec 2023 report, 6.9× the same report last year.

Short interest spike, became public on 11 Jan 2024

Same report last year: 341K; its normal report is 333K.

See the evidence
This period
2.4M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
333K
Typical spread (median absolute deviation)
63K
How far from its usual level
+21.5
Same report last year
341K
History used
2,191 days
2022-12-30: 341K2023-01-13: 343K2023-01-31: 328K2023-02-15: 311K2023-02-28: 338K2023-03-15: 353K2023-03-31: 275K2023-04-14: 264K2023-04-28: 266K2023-05-15: 295K2023-05-31: 256K2023-06-15: 258K2023-06-30: 275K2023-07-14: 274K2023-07-31: 277K2023-08-15: 315K2023-08-31: 401K2023-09-15: 548K2023-09-29: 669K2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.4M2023-11-30: 1.5M2023-12-15: 2.1M2023-12-29: 2.4M
the 29 Dec 2023 report24 earlier reportsnormal: 333K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.